BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20698224)

  • 1. Relationship between period of survival and clinicopathological characteristics in patients with hepatocellular carcinoma who underwent hepatectomy.
    Nanashima A; Abo T; Tobinaga S; Kunizaki M; Hidaka S; Nonaka T; Miuma S; Taura N; Miyaaki H; Nakashima M; Sawai T; Nakao K; Nagayasu T
    Hepatogastroenterology; 2010; 57(99-100):540-6. PubMed ID: 20698224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC.
    Toyoda H; Kumada T; Kaneoka Y; Osaki Y; Kimura T; Arimoto A; Oka H; Yamazaki O; Manabe T; Urano F; Chung H; Kudo M; Matsunaga T
    J Hepatol; 2008 Aug; 49(2):223-32. PubMed ID: 18571271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma.
    Hayashi M; Shimizu T; Hirokawa F; Inoue Y; Komeda K; Asakuma M; Miyamoto Y; Takeshita A; Shibayama Y; Tanigawa N
    Am Surg; 2011 May; 77(5):572-8. PubMed ID: 21679590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma.
    Masuda T; Beppu T; Horino K; Komori H; Hayashi H; Okabe H; Otao R; Horlad H; Ishiko T; Takamori H; Kikuchi K; Baba H
    J Surg Oncol; 2010 Oct; 102(5):490-6. PubMed ID: 19937994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
    Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.
    Nanashima A; Omagari K; Tobinaga S; Shibata K; Sumida Y; Mine M; Morino S; Shibasaki S; Ide N; Shindou H; Nagayasu T
    Eur J Surg Oncol; 2005 Oct; 31(8):882-90. PubMed ID: 15993031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
    Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
    Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
    Yokoi Y; Suzuki S; Baba S; Inaba K; Konno H; Nakamura S
    J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of major hepatectomy for large hepatocellular carcinoma.
    Miyoshi A; Takahashi T; Otsuka T; Kohya N; Miyazaki K
    Hepatogastroenterology; 2009; 56(91-92):768-72. PubMed ID: 19621699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
    Shimozawa N; Hanazaki K
    J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: subgroup analysis according to Milan criteria.
    Yamamoto J; Kosuge T; Saiura A; Sakamoto Y; Shimada K; Sano T; Takayama T; Sugawara Y; Yamaguchi T; Kokudo N; Makuuchi M
    Jpn J Clin Oncol; 2007 Apr; 37(4):287-95. PubMed ID: 17553819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of histological vascular invasion from preoperative evaluation in patients with hepatocellular carcinoma who underwent living donor liver transplantation.
    Sakai K; Okajima H; Koshino K; Suzuki T; Nobori S; Matsuyama M; Ushigome H; Ochiai T; Yoshimura N
    Transplant Proc; 2012 Mar; 44(2):409-11. PubMed ID: 22410029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple positive tumor markers for hepatocellular carcinoma are useful predictors of poor survival.
    Kiriyama S; Uchiyama K; Ueno M; Ozawa S; Hayami S; Tani M; Yamaue H
    Ann Surg; 2011 Dec; 254(6):984-91. PubMed ID: 21606837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between period of survival and clinicopathological characteristics in patients with colorectal liver metastasis.
    Nanashima A; Araki M; Tobinaga S; Kunizaki M; Hidaka S; Shibata K; Mochinaga K; Sawai T; Isomoto H; Ohnita K; Uehara M; Nagayasu T
    Eur J Surg Oncol; 2009 May; 35(5):504-9. PubMed ID: 19167860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LCSGJ-T classification, 6th or 5th edition TNM staging did not independently predict the long-term prognosis of HBV-related hepatocellular carcinoma after radical hepatectomy.
    Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
    J Surg Res; 2010 Mar; 159(1):538-44. PubMed ID: 19111323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.
    Dahiya D; Wu TJ; Lee CF; Chan KM; Lee WC; Chen MF
    Surgery; 2010 May; 147(5):676-85. PubMed ID: 20004441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of early hepatocellular carcinoma after hepatic resection.
    Maeda T; Shimada M; Harimoto N; Tsujita E; Aishima S; Tanaka S; Shirabe K; Maehara Y
    Hepatogastroenterology; 2008; 55(85):1428-32. PubMed ID: 18795705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection.
    Yang LY; Fang F; Ou DP; Wu W; Zeng ZJ; Wu F
    Ann Surg; 2009 Jan; 249(1):118-23. PubMed ID: 19106686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.